Second Sight Medical (EYES) Tops Q3 EPS by 1c

Second Sight Medical (NASDAQ: EYES) reported Q3 EPS of ($0.15), $0.01 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $1.2 million versus the consensus estimate of $2.36 million.

For earnings history and earnings-related data on Second Sight Medical (EYES) click here.

You May Also Be Interested In

• Tredegar Corp. (TG) Tops Q2 EPS by 18c
• King Pharmaceuticals (KG) Misses Q2 EPS by 103c
• Mammoth Energy Services (TUSK) Reports Q2 Loss of $0.01